carvedilol has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magadmi, RM | 1 |
| Alsulaimani, MA | 1 |
| Al-Rafiah, AR | 1 |
| Esmat, A | 1 |
| Akinlade, OM | 1 |
| Owoyele, B | 1 |
| Soladoye, OA | 1 |
2 other studies available for carvedilol and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An
Topics: Activating Transcription Factor 3; Animals; Carvedilol; Cell Shape; Cell Survival; Diabetic Neuropat | 2021 |
Carvedilol improves heart rate variability indices, biomarkers but not cardiac nerve density in streptozotocin-induced T2DM model of diabetic cardiac autonomic neuropathy.
Topics: Animals; Biomarkers; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Heart Rate; Human | 2021 |